Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moussalli

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Journal of Viral Hepatitis|May 8, 1998
Management of hepatitis CJ Moussalli, P Opolon, T Poynard
Clinics in Liver Disease|April 9, 2001
Effect of interferon therapy on the natural history of hepatitis C virus-related cirrhosis and hepatocellular carcinomaT Poynard, J Moussalli, V Ratziu, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|July 1, 1989
Influence of human breast development on the growth properties of primary culturesJ Russo, M J Mills, M J Moussalli, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Neuro-lupus associated with Zollinger-Ellison syndrome with hepatic metastases: an incidental association?]J F Cadranel, P Ruszniewski, E Lebiez, et al.
European Journal of Gastroenterology & Hepatology|February 21, 1998
Acute hepatitis during hypersensitivity syndrome due to midecamycinT Thevenot, P Mathurin, F Martinez, et al.
Cancer Medicine|March 18, 2014
15-LOX-1 suppression of hypoxia-induced metastatic phenotype and HIF-1α expression in human colon cancer cellsYuanqing Wu, Fei Mao, Xiangsheng Zuo, et al.
Journal of Viral Hepatitis|July 1, 1997
Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirinT Thevenot, P Mathurin, J Moussalli, et al.
Journal of Viral Hepatitis|March 6, 2002
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trialT Poynard, F Imbert-Bismut, V Ratziu, et al.
Gastroenterologie Clinique Et Biologique|August 6, 2008
[Alcohol, steatohepatitis, insulin resistance and hepatitis C]P Couzigou, P Mathurin, L Serfaty, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 22, 2022
deepOrganoid: A brightfield cell viability model for screening matrix-embedded organoidsReid T Powell, Micheline J Moussalli, Lei Guo, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Journal of Viral Hepatitis|May 8, 1998
Management of hepatitis CJ Moussalli, P Opolon, T Poynard
Clinics in Liver Disease|April 9, 2001
Effect of interferon therapy on the natural history of hepatitis C virus-related cirrhosis and hepatocellular carcinomaT Poynard, J Moussalli, V Ratziu, et al.
In Vitro Cellular & Developmental Biology : Journal of the Tissue Culture Association|July 1, 1989
Influence of human breast development on the growth properties of primary culturesJ Russo, M J Mills, M J Moussalli, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Neuro-lupus associated with Zollinger-Ellison syndrome with hepatic metastases: an incidental association?]J F Cadranel, P Ruszniewski, E Lebiez, et al.
European Journal of Gastroenterology & Hepatology|February 21, 1998
Acute hepatitis during hypersensitivity syndrome due to midecamycinT Thevenot, P Mathurin, F Martinez, et al.
Cancer Medicine|March 18, 2014
15-LOX-1 suppression of hypoxia-induced metastatic phenotype and HIF-1α expression in human colon cancer cellsYuanqing Wu, Fei Mao, Xiangsheng Zuo, et al.
Journal of Viral Hepatitis|July 1, 1997
Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirinT Thevenot, P Mathurin, J Moussalli, et al.
Journal of Viral Hepatitis|March 6, 2002
Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trialT Poynard, F Imbert-Bismut, V Ratziu, et al.
Gastroenterologie Clinique Et Biologique|August 6, 2008
[Alcohol, steatohepatitis, insulin resistance and hepatitis C]P Couzigou, P Mathurin, L Serfaty, et al.
SLAS Discovery : Advancing Life Sciences R & D|March 22, 2022
deepOrganoid: A brightfield cell viability model for screening matrix-embedded organoidsReid T Powell, Micheline J Moussalli, Lei Guo, et al.
Pageof 4